Harvey Partners, LLC Harvard Bioscience Inc Transaction History

Harvey Partners, LLC

$962 Million
Q2 2025

A detailed history of Harvey Partners, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Harvey Partners, LLC holds 2,141,099 shares of HBIO stock, worth $1.03 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,141,099

Previous 2,187,500 2.12%

Holding current value

$1.03 Million

Previous $1.25 Million 24.4%

% of portfolio

0.1%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.28 - $0.69 $12,992 - $32,016	-46,401 Reduced 2.12%	2,141,099 $942,000
Q1 2025 May 15, 2025	SELL	$0.57 - $2.19 $282,435 - $1.09 Million	-495,500 Reduced 18.47%	2,187,500 $1.25 Million
Q4 2024 Feb 14, 2025	SELL	$2.02 - $2.82 $64,640 - $90,240	-32,000 Reduced 1.18%	2,683,000 $5.66 Million
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $415,800 - $557,550	157,500 Added 6.16%	2,715,000 $7.3 Million
Q4 2023 Feb 14, 2024	BUY	$4.0 - $5.49 $134,000 - $183,915	33,500 Added 1.33%	2,557,500 $13.7 Million
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $790,653 - $1.16 Million	-188,700 Reduced 6.96%	2,524,000 $13.9 Million
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $487,060 - $838,936	-198,800 Reduced 6.83%	2,712,700 $11.4 Million
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $424 - $572	200 Added 0.01%	2,911,500 $8.06 Million
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $107,879 - $181,496	46,300 Added 1.62%	2,911,300 $7.45 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $2.1 Million - $4.1 Million	639,000 Added 28.71%	2,865,000 $10.3 Million
Q1 2022 May 16, 2022	BUY	$5.16 - $7.14 $4.96 Million - $6.86 Million	961,000 Added 75.97%	2,226,000 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $1.56 Million - $2 Million	244,964 Added 24.02%	1,265,000 $8.92 Million
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $558,148 - $677,295	-79,964 Reduced 7.27%	1,020,036 $7.12 Million
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $418,370 - $747,930	107,000 Added 10.78%	1,100,000 $6.01 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $609,000 - $913,500	203,000 Added 25.7%	993,000 $4.26 Million
Q3 2020 Nov 16, 2020	SELL	$2.75 - $4.2 $97,625 - $149,100	-35,500 Reduced 4.3%	790,000 $2.38 Million
Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.14 $1.87 Million - $2.77 Million	-882,966 Reduced 51.68%	825,500 $2.56 Million
Q1 2020 May 15, 2020	BUY	$1.42 - $3.29 $989,406 - $2.29 Million	696,765 Added 68.87%	1,708,466 $3.78 Million
Q4 2019 Feb 14, 2020	BUY	$2.45 - $3.25 $659,542 - $874,903	269,201 Added 36.26%	1,011,701 $3.09 Million
Q3 2019 Nov 14, 2019	BUY	$1.59 - $3.47 $1.18 Million - $2.58 Million	742,500 New	742,500 $2.28 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

22.5M

Call Options Held

101K

Put Options Held

22K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $20M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Partners, LLC with notifications on news.

Account

Harvey Partners, LLC Harvard Bioscience Inc Transaction History